OpenAI is rolling out an ad test in ChatGPT for logged-in adult users on Free and Go tiers in the United States, with paid plans (Plus, Pro, Business, Enterprise, Education) remaining ad-free. Ads are clearly labeled, visually separated from answers, and personalized using in-session data that is not shared with advertisers. The system excludes ads from sensitive topics (health, mental health, politics) and users predicted to be under 18, with user controls for dismissal and data deletion.
OpenAI has announced it is beginning to test advertising within ChatGPT as a mechanism to support free-tier access. The company states ads will be clearly labeled, will not influence answer content, and will include privacy protections and user controls. This marks a significant monetization strategy shift for OpenAI's flagship consumer product.
OpenAI announced ChatGPT Plus, a paid subscription tier for ChatGPT priced at $20/month. The plan offers subscribers faster response times, priority access during peak periods, and early access to new features. This marks OpenAI's first direct consumer monetization of ChatGPT following its rapid growth after the November 2022 launch.
OpenAI announced ChatGPT Pro, a new subscription tier aimed at broadening access to frontier AI capabilities. The announcement comes from OpenAI's official blog and signals a product and pricing strategy move to expand usage of their most advanced models. Details on specific model access, pricing, and feature differentiation were not included in the provided body text.
OpenAI has launched ChatGPT Go as a new globally available subscription tier, providing access to GPT-5.2 Instant with higher usage limits and extended memory capabilities. The offering is positioned as a more affordable entry point to advanced AI features for users worldwide. This represents a new pricing and access tier in OpenAI's consumer product lineup.
OpenAI announced ChatGPT Edu, an affordable tier of ChatGPT designed specifically for university deployment. The offering aims to help higher education institutions responsibly integrate AI into campus life. This is a product launch targeting the academic sector with pricing and governance features suited for institutional use.
OpenAI is launching GPT-4o, its newest flagship model, and expanding access to additional capabilities for free-tier ChatGPT users. This represents a significant democratization move, bringing frontier model capabilities to users without a paid subscription. The announcement signals OpenAI's strategy to broaden its user base while maintaining competitive pressure on rivals.
OpenAI is launching ChatGPT for Clinicians, a free, dedicated workspace for verified US clinicians accessible under an existing ChatGPT account. The product targets point-of-care use cases including evidence review, clinical documentation, medical literature research, and CME credit support. It includes trusted clinical search, citations, and reusable skills. This marks OpenAI's first explicit product targeting licensed healthcare professionals at the point of care.
OpenAI is deploying a behavioral and account-level age prediction model on ChatGPT consumer plans to identify users likely under 18 and apply appropriate safeguards. The model uses signals including account age, activity timing, usage patterns, and stated age. Adults incorrectly flagged can verify their age via selfie through Persona, a third-party identity verification service.